Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039878 | SCV000063569 | benign | not specified | 2015-11-09 | criteria provided, single submitter | clinical testing | p.Val4040Met in exon 51 of TTN: This variant is not expected to have clinical si gnificance because it has been identified in 1.2% (121/9780) of African chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs66839174). |
Genetic Services Laboratory, |
RCV000039878 | SCV000153174 | likely benign | not specified | 2014-08-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000039878 | SCV000238222 | benign | not specified | 2015-06-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000232564 | SCV000286457 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839496 | SCV002100060 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839497 | SCV002100061 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839498 | SCV002100062 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839495 | SCV002100063 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000039878 | SCV003923260 | likely benign | not specified | 2023-03-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003326337 | SCV004033831 | benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | TTN: BS1, BS2 |
Laboratory of Diagnostic Genome Analysis, |
RCV000039878 | SCV001800398 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000039878 | SCV001922825 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000039878 | SCV001957857 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000039878 | SCV001972119 | benign | not specified | no assertion criteria provided | clinical testing |